Start a dossier
We resolve the name to its registry identifiers and let you confirm the exact legal entity before generating. From $299 per dossier.
The spine
Ten chapters, each grounded in a named registry.
Identity & corporate structure
OpenCorporates · Companies House · GLEIF
Financial profile
SEC EDGAR 10-K / 10-Q · segment data
Funding & M&A history
SEC Form D · deal records
IP portfolio
USPTO PatentsView · Google Patents
Litigation & legal footprint
CourtListener (US federal dockets)
Government exposure
SAM.gov (contracts & registration)
Regulatory footprint
openFDA · ClinicalTrials.gov · sector regulators
Market context
Meridian market models
Adverse signals & red flags
Synthesized across filings & dockets
Diligence summary & coverage note
Confidence + what was not found
Built on primary registries, not scraped aggregators
How it works
Name it. Confirm it. Read it.
Name the entity
Type a company. We resolve it against SEC EDGAR, GLEIF, OpenCorporates, and Companies House to its registry identifiers: CIK, LEI, company number.
Confirm the match
You pick the exact legal entity from the candidates, so the dossier never conflates a look-alike, or a subsidiary with its parent.
Grounded dossier
Ten chapters assembled from primary filings, every claim cited and machine-verified, delivered to your workspace.
Why it holds up
Grounded, resolved, and honest about its limits.
Primary-source grounded
Every figure and claim traces to the originating filing and passes the same claim-verification audit as our market reports. No unsourced assertions.
Entity-resolved
Resolved to CIK, LEI, and company number before a word is written, and you confirm the match. The dossier is about the right legal entity, not a name-alike.
US · UK · EU registries
SEC EDGAR, Companies House, GLEIF, OpenCorporates, CourtListener, USPTO, SAM.gov: primary registries, not scraped aggregators.
Market context built in
Cross-linked to Meridian's market models: where the entity sits, its share, the markets it competes in. Pure-play diligence vendors can't show this.
Adverse-signal pass
A dedicated read for litigation spikes, enforcement actions, and risk-factor language: flagged, with the source attached.
Coverage-honest
Thin coverage is stated, not hidden. The closing note records what was found, what was not, and the confidence behind each chapter.
Pricing
One entity, one price. No seat license.
Dossier
The full 10-chapter dossier
- Scope
- 1 entity · 10 chapters
- Delivery
- Minutes · A4 PDF + workspace
- All 10 chapters, entity-resolved
- Identity, financials, funding & M&A
- IP portfolio + litigation footprint
- Government & regulatory exposure
- Market-context cross-link to Meridian models
- Numbered citations → primary filings
- Coverage & confidence note
- A4 PDF export + workspace access
Commercial diligence, partner vetting, and competitor deep-dives on a named company.
Start with a company nameDossier Pro
RecommendedDeeper risk scan + analyst call
- Scope
- 1 entity · 10 chapters · personalized
- Delivery
- Priority queue · landscape PDF
- Everything in Dossier
- Deep adverse-media & litigation scan
- Ownership graph (parent / subsidiaries)
- Named-recipient masthead (Prepared for [Name])
- 30-minute analyst consultation call
- Priority generation queue
- Methodology appendix on request
Deal teams and acquirers vetting a target where the downside of a missed signal is real.
Start with a company nameRunning diligence at volume? Talk to the desk about a Diligence Desk subscription with unlimited lookups for active deal teams.
Commercial diligence, not regulated screening
Meridian Dossier is market and commercial intelligence on a named entity. It is nota KYC, AML, sanctions, PEP, or credit-screening product, and must not be used as the sole basis for a regulated compliance or lending decision. For sanctions, PEP, or credit screening, use a regulated provider such as Dun & Bradstreet, Moody's Orbis, or LSEG World-Check. Every dossier is assembled on the same primary-source, claim-verified research methodology as our market reports.
Questions
What buyers ask first.
How is a Meridian Dossier different from Consensus and Compass?
Consensus sizes a market, TAM, CAGR, segmentation, country breakdowns. Compass produces B2B strategy and performance-marketing dossiers. Meridian Dossier profiles a single company or entity, filings, funding, IP, litigation, and government/regulatory exposure, for diligence on a named target.
Is this KYC, AML, or sanctions screening?
No. Meridian Dossier is commercial and market diligence on a named entity. It is NOT a KYC, AML, sanctions, PEP, or credit-screening product and must not be used as the sole basis for a regulated compliance decision. For sanctions / PEP / credit screening, use a regulated provider such as Dun & Bradstreet, Moody's Orbis, or LSEG World-Check.
Which entities can I run?
Public and private companies. Coverage is strongest for entities registered in the US, UK, and EU, where primary registries are queryable; it degrades elsewhere, and the coverage note in every dossier states exactly what was and was not available.
Where does the data come from?
Primary registries and filings only: SEC EDGAR, SEC Form D, OpenCorporates, Companies House (UK), GLEIF, CourtListener, USPTO PatentsView, SAM.gov, openFDA, and ClinicalTrials.gov, each cited inline.
How long does generation take?
A dossier assembles in minutes once you confirm the entity, then lands in your workspace after a short quality pass. Pro runs a deeper adverse-signal scan on a priority queue.
What if the filings are thin?
Chapters with no retrievable evidence are flagged rather than invented, and the dossier status reflects partial coverage. You are never billed into a confident-sounding report built on nothing.
Part of Meridian Consensus: market reports · research methodology